Interlace launches MyoSure trial

March 30, 2010 by MassDevice staff

Interlace Medical Inc. launched a clinical trial of its MyoSure fibroid surgery device, aiming to prove that women experience little pain or discomfort during the procedure.

The Framingham, Mass.-based firm's myomectomy system is a minimally invasive technique that allows for the removal of submucosal fibroids and polyps in a single, out-patient procedure. Submucosal fibroids are benign tumors that grow just beneath the endometrial lining of the uterus.

Permalink